Bioequivalence Requirements In Various Global Jurisdictions
Download Bioequivalence Requirements In Various Global Jurisdictions full books in PDF, epub, and Kindle. Read online free Bioequivalence Requirements In Various Global Jurisdictions ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: Isadore Kanfer |
Publisher |
: Springer |
Total Pages |
: 348 |
Release |
: 2017-12-05 |
ISBN-10 |
: 9783319680781 |
ISBN-13 |
: 3319680781 |
Rating |
: 4/5 (81 Downloads) |
Synopsis Bioequivalence Requirements in Various Global Jurisdictions by : Isadore Kanfer
Although the Bioequivalence (BE) requirements in many global jurisdictions have much in common, differences in certain approaches and requirements such as definitions and terms, choice of comparator (reference) product, acceptance criteria, fasted and fed studies, single and multi-dose studies, biowaivers and products not intended for absorption into the systemic circulation (locally acting medicines and dosage forms), amongst others, provide food for thought that standardisation should be a high priority objective in order to result in a harmonized international process for the market approval of products using BE. An important objective of Bioequivalence Requirements in Various Global Jurisdictions is to attempt to gather the various BE requirements used in different global jurisdictions to provide a single source of relevant information. This information from, Brazil, Canada, China, European Union, India, Japan, MENA, Russia South Africa, the USA and WHO will be of value to drug manufacturers, regulatory agencies, pharmaceutical scientists and related health organizations and governments around the world in the quest to harmonize regulatory requirements for the market approval of generic products.
Author |
: National Academies of Sciences, Engineering, and Medicine |
Publisher |
: National Academies Press |
Total Pages |
: 169 |
Release |
: 2020-04-25 |
ISBN-10 |
: 9780309498630 |
ISBN-13 |
: 0309498635 |
Rating |
: 4/5 (30 Downloads) |
Synopsis Regulating Medicines in a Globalized World by : National Academies of Sciences, Engineering, and Medicine
Globalization is rapidly changing lives and industries around the world. Drug development, authorization, and regulatory supervision have become international endeavors, with most medicines becoming global commodities. Drug companies utilize global supply chains that often include facilities in countries with inconsistent regulations from those of the United States, perform pivotal trials in multiple countries to support registration submissions in various jurisdictions, and subsequently market their medicines throughout most of the world. These companies operate across borders and require individual national regulators to ensure that drugs authorized for use in their countries are safe and effective, and appropriate for their health care system and their population. This process involves significant resources and often duplicative work. It is important to consider how this process can be improved in order to better allocate resources, time, and efforts to improve public health. Regulating Medicines in a Globalized World: The Need for Increased Reliance Among Regulators considers the role of mutual recognition and other reliance activities among regulators in contributing to enhancing public health. This report identifies opportunities for leveraging reliance activities more broadly in order to potentially impact public health globally. Key topics in this report include the job of medicines regulators in today's world, what policy makers need to know about today's regulatory environment, stakeholder views of recognition and reliance, as well as removing impediments and facilitating action for greater recognition and reliance among regulatory authorities.
Author |
: Isadore Kanfer |
Publisher |
: CRC Press |
Total Pages |
: 334 |
Release |
: 2016-04-19 |
ISBN-10 |
: 9781420020021 |
ISBN-13 |
: 1420020021 |
Rating |
: 4/5 (21 Downloads) |
Synopsis Generic Drug Product Development by : Isadore Kanfer
Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutica
Author |
: |
Publisher |
: World Health Organization |
Total Pages |
: 70 |
Release |
: 2020-09-29 |
ISBN-10 |
: 9789240011878 |
ISBN-13 |
: 9240011870 |
Rating |
: 4/5 (78 Downloads) |
Synopsis WHO guideline on country pharmaceutical pricing policies by :
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Author |
: Kung-Chung Liu |
Publisher |
: Springer Nature |
Total Pages |
: 513 |
Release |
: 2019-09-06 |
ISBN-10 |
: 9789811381027 |
ISBN-13 |
: 981138102X |
Rating |
: 4/5 (27 Downloads) |
Synopsis Innovation, Economic Development, and Intellectual Property in India and China by : Kung-Chung Liu
This open access book analyses intellectual property codification and innovation governance in the development of six key industries in India and China. These industries are reflective of the innovation and economic development of the two economies, or of vital importance to them: the IT Industry; the film industry; the pharmaceutical industry; plant varieties and food security; the automobile industry; and peer production and the sharing economy. The analysis extends beyond the domain of IP law, and includes economics and policy analysis. The overarching concern that cuts through all chapters is an inquiry into why certain industries have developed in one country and not in the other, including: the role that state innovation policy and/or IP policy played in such development; the nature of the state innovation policy/IP policy; and whether such policy has been causal, facilitating, crippling, co-relational, or simply irrelevant. The book asks what India and China can learn from each other, and whether there is any possibility of synergy. The book provides a real-life understanding of how IP laws interact with innovation and economic development in the six selected economic sectors in China and India. The reader can also draw lessons from the success or failure of these sectors.
Author |
: Ratanawijitrasin S |
Publisher |
: World Health Organization |
Total Pages |
: 202 |
Release |
: 2002-06 |
ISBN-10 |
: 9789241562065 |
ISBN-13 |
: 9241562064 |
Rating |
: 4/5 (65 Downloads) |
Synopsis Effective Drug Regulation by : Ratanawijitrasin S
Seven independent variables were used including the five financing instruments, the firm's ordinary debt, and the firm's operating risk.
Author |
: Institute of Medicine |
Publisher |
: National Academies Press |
Total Pages |
: 377 |
Release |
: 2013-06-20 |
ISBN-10 |
: 9780309269391 |
ISBN-13 |
: 0309269393 |
Rating |
: 4/5 (91 Downloads) |
Synopsis Countering the Problem of Falsified and Substandard Drugs by : Institute of Medicine
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.
Author |
: Michael K. Pugsley |
Publisher |
: Springer |
Total Pages |
: 477 |
Release |
: 2015-06-19 |
ISBN-10 |
: 9783662469439 |
ISBN-13 |
: 366246943X |
Rating |
: 4/5 (39 Downloads) |
Synopsis Principles of Safety Pharmacology by : Michael K. Pugsley
This book illustrates, in a comprehensive manner, the most current areas of importance to Safety Pharmacology, a burgeoning unique pharmacological discipline with important ties to academia, industry and regulatory authorities. It provides readers with a definitive collection of topics containing essential information on the latest industry guidelines and overviews current and breakthrough topics in both functional and molecular pharmacology. An additional novelty of the book is that it constitutes academic, pharmaceutical and biotechnology perspectives for Safety Pharmacology issues. Each chapter is written by an expert in the area and includes not only a fundamental background regarding the topic but also detailed descriptions of currently accepted, validated models and methods as well as innovative methodologies used in drug discovery.
Author |
: World Intellectual Property Organization |
Publisher |
: WIPO |
Total Pages |
: 259 |
Release |
: 2013 |
ISBN-10 |
: 9789280523089 |
ISBN-13 |
: 9280523082 |
Rating |
: 4/5 (89 Downloads) |
Synopsis Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade by : World Intellectual Property Organization
This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.
Author |
: Jennifer B. Dressman |
Publisher |
: CRC Press |
Total Pages |
: 432 |
Release |
: 2016-04-19 |
ISBN-10 |
: 9781420077346 |
ISBN-13 |
: 1420077341 |
Rating |
: 4/5 (46 Downloads) |
Synopsis Oral Drug Absorption by : Jennifer B. Dressman
Oral Drug Absorption, Second Edition thoroughly examines the special equipment and methods used to test whether drugs are released adequately when administered orally. The contributors discuss methods for accurately establishing and validating in vitro/in vivo correlations for both MR and IR formulations, as well as alternative approaches for MR an